Antibody-based therapeutics: Focus on prostate cancer

Author： Ross Jeffrey   Gray Karen   Webb Iain   Gray Gary   Rolfe Mark   Schenkein David   Nanus David   Millowsky Mathew   Bander Neil  

Publisher： Springer Publishing Company

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.24, Iss.4, 2005-12, pp. : 521-537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

CD44v6: a target for antibody-based cancer therapy

By Heider Karl-Heinz   Kuthan Hartmut   Stehle Gerd   Munzert Gerd  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 567-579

Springer Publishing Company

Access to resources Recommend Favorite

Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Ceramide-Based Therapeutics for the Treatment of Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 9, 2011-11 ,pp. : 911-919

Bentham Science Publishers

Access to resources Recommend Favorite

Adenovirus-based Immunotherapy for Prostate Cancer

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 264-270

Bentham Science Publishers

Access to resources Recommend Favorite